Scientists test immune cells against rare skin cancer in the lab
NCT ID NCT06780475
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new cell therapy in the lab for people with Merkel cell carcinoma, a rare skin cancer linked to a virus. Researchers will take immune cells from 15 patients and try to train them to attack the cancer in a test tube. The goal is to see if this approach works before moving to patient treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MERKEL CELL CARCINOMA OF SKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dermato-oncology Department, Ambroise Paré Hospital, APHP
RECRUITINGBoulogne-Billancourt, 92100, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.